Click here to return to the Reference Table

Category: Carcinomas
Cancer type: Cholangiocarcinoma
Descriptor: Therapeutic Development

Reference Number: 671
Socoteanu MP, Mott F, Alpini G, Frankel AE. c-Met targeted therapy of cholangiocarcinoma. World J Gastroenterol. 14, 2990-4 (2008)
PubMed link      E-mail link

Reference Number: 1315
Ge X, Wang Y, Wang Y, Li Q, Yu H, Miao L. NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells. Dig Dis Sci. 58, 1636-43 (2013)
PubMed link      E-mail link

Reference Number: 1405
Ge X1, Wang Y, Li Q, Yu H, Ji G, Miao L. NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway. Oncol Rep. 30, 448-54 (2013)
PubMed link      E-mail link